Although indicators of central obesity have been suggested as a better alternative to body mass index (BMI), yet mixed results exist. This study examined whether waist circumference (WC) was better in identifying metabolic disorders than BMI at two time points. This study used nationally representative 1998 and 2005 Korea National Health and Nutrition Examination Survey data sets. Odds ratios from logistic regressions and area under the curves (AUC) were calculated. BMI and WC showed similar level of odds ratios (1.1-1.6) to diabetes, hypertension, dyslipidemia and having two or three metabolic syndrome criteria. The AUC comparison, however, indicated that, in only women, WC was a better discriminator for diabetes, hypertension and having two or three metabolic syndrome criteria. No meaningful differences were found between 1998 and 2005. Prospective studies to weigh practical and clinical relevance are needed to assert the use of WC over BMI in clinical and public health settings. 
Introduction
Obesity is an important global public health problem because of its increasing prevalence and its associations with many chronic diseases (WHO, 2000b) . Appropriately, there is much interest in identifying indicators of obesity that can better identify individuals with chronic diseases, especially metabolic disorders (Nishida et al., 2010) . Although indicators of central obesity have been suggested as a better alternative to body mass index (BMI), the results have been mixed. Studies have found that indicators of central obesity were better (Lee et al., 2008; The Decoda Study Group, 2008; Huxley et al., 2008 Huxley et al., , 2010 or similar to BMI (Vazquez et al., 2007; The Obesity in Asia Collaboration, 2008; Qiao and Nyamdorj, 2010) .
This study aimed to (1) determine the association between obesity indicators (BMI and waist circumference (WC)) and metabolic disorders (diabetes, hypertension and dyslipidemia) and (2) compare the two obesity indicators as discriminators of metabolic disorder risk, using the 1998 and 2005 nationally representative Korea National Health and Nutrition Examination Survey (KNHANES) data sets. This study would add information from a more recent data set and report on the less frequently studied dyslipidemia. The use of the temporarily separated data sets allowed assessment of the result consistency over time. Metabolic disorders included diabetes, hypertension, high triglyceride, high total cholesterol, low high-density lipoprotein (HDL)-cholesterol and high low-density lipoprotein (LDL)-cholesterol levels. Individuals were considered to have diabetes if they reported diabetes or if their fasting blood glucose level was X6.99 mM (126 mg per 100 ml). Hypertension was categorized by either self-report of hypertension or by measurement of high blood pressure. Cutoff value for systolic pressure was X140 mm Hg and those for diastolic pressure was X90 mm Hg. Individuals were grouped to have high triglyceride if their fasting triglyceride level exceeded 1.70 mM (150 mg per 100 ml). Total cholesterol, low HDL-cholesterol and high LDL-cholesterol were also measured from fasting blood. Cutoff values for total cholesterol and high LDLcholesterol was 5.18 mM (200 mg per 100 ml) and 3.37 mM (130 mg per 100 ml), respectively. For low HDL-cholesterol, 1.04 mM (40 mg per 100 ml) was used as cutoff value for men, whereas 1.30 mM (50 mg per 100 ml) was used for women.
Subjects and methods

Participants
Although no internationally agreed diagnostic criteria for metabolic syndrome exist at this time, five well-known criteria have been proposed, which include criteria of WHO or National Cholesterol Education Program-Adult Treatment Panel III. Each proposed criterion has different combinations and cutoff values. However, all criteria proposed to consider individuals to have metabolic syndrome if they have a minimum of three of the five clinical measures over the cutoff values. As BMI and/or WC are one of the clinical measures, this study examined individuals with two or three metabolic diseases other than BMI or WC.
Statistical analysis SAS 9.1 for PC was used for statistical analyses. Association between the obesity indicators and metabolic disorders was examined by obtaining age-adjusted odds ratios for metabolic diseases associated with 0.5 s.d. increment in each of the obesity indicators for each sex. Discriminatory power of the obesity indicators was compared by calculating the areas under the receiver operating characteristic curves for each sex.
Results
Obesity and metabolic disorder status
The average BMIs for men and women did not differ between the two surveys, however, the proportions of men with a BMI of 25 and above, increased from 25.0% in 1998 to 35 Association between obesity indicators and metabolic disorders BMI and WC showed similar levels of association with various metabolic disorders. No significant differences were found between sexes and two surveys ( Table 1) .
Comparison of obesity indicators for discrimination of metabolic disorder risk No differences were found among men. However, for women, WC was superior to BMI in discriminating individuals with diabetes, hypertension and having two or three metabolic syndrome criteria (Table 2) .
Discussion
This study found that BMI and WC showed similar levels of association with diabetes, hypertension, dyslipidemia, having two or three metabolic syndrome criteria in both men and women. However, the area under curve (AUC) comparison revealed WC to be a superior discriminator for diabetes, hypertension and having two or three metabolic syndrome criteria in women, but not in men. No differences between WC and BMI were found with dyslipidemia. These findings were consistent across the two surveys. This consistency could remove concerns of possible temporal change because of behavioral and other trends. The sizes of odds ratios and AUC analyzed from a recent data set in this study were very comparable to those previously reported (Vazquez et al., 2007; Lee et al., 2008; The Decoda Study Group, 2008; The Obesity in Asia Collaboration, 2008; Huxley et al., 2008 Huxley et al., , 2010 Qiao and Nyamdorj, 2010) , although the differences among women were more pronounced in this study. Results of this study seem to suggest the use of WC over BMI, especially for women. However, interpretive caution is required given the cross-sectional study design. In addition to the small, albeit significant, differences of AUC between BMI and WC, in which cutoff points are most desirable and clinically relevant for both WC and BMI to identify individuals remain unresolved (Tuan et al., 2009; Huxley et al., 2010; Qiao and Nyamdorj, 2010) . As WC is a more sensitive, but difficult, measure to use, more prospective studies to weigh practical and clinical relevance are needed before WC can be recommended over BMI in clinical and public health settings.
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